Table of Contents
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Type of SCID
- 5.2. Therapy Type
- 5.3. Vector Type
- 5.4. Patient Age Group
- 5.5. Pricing Model
- 5.6. Phase of Development
- 5.7. End-User
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type of SCID
- 6.1. X-Linked SCID
- 6.2. ADA-SCID
- 6.3. Other SCID Types
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy Type
- 7.1. Gene Replacement Therapy
- 7.2. Gene Editing Therapy
- 7.3. Stem Cell Gene Therapy
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Vector Type
- 8.1. Viral Vectors
- 8.2. Non-Viral Vectors
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Patient Age Group
- 9.1. Pediatric Patients
- 9.2. Adult Patients
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Pricing Model
- 10.1. Single-dose treatments
- 10.2. Multi-dose treatments
11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phase of Development
- 11.1. Preclinical
- 11.2. Clinical Trials
- 11.3. Commercialized
12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User
- 12.1. Hospitals
- 12.2. Specialty Clinics
- 12.3. Research Institutions
13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 13.1. North America
- 13.2. Latin America
- 13.3. Western Europe
- 13.4. Eastern Europe
- 13.5. East Asia
- 13.6. South Asia & Pacific
- 13.7. MEA
14. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
18. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
19. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
20. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
21. Sales Forecast 2024 to 2034 by Type of SCID, Therapy Type, Vector Type, Patient Age Group, Pricing Model, Phase of Development, and End-User for 30 Countries
22. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
23. Company Profile
- 23.1. Orchard Therapeutics plc.
- 23.2. OSR and Telethon
- 23.3. Jasper Therapeutics, Inc.
- 23.4. Graphite Bio, Inc.
- 23.5. Mustang Bio Inc
- 23.6. University of California San Francisco
- 23.7. Genethon SA
- 23.8. Boston Children's Hospital
- 23.9. Shenzhen Geno-Immune Medical Institute
- 23.10. University College London
- 23.11. University of California Los Angeles
- 23.12. The National Institute of Allergy and Infectious Diseases
List of Tables
Table 1: Global Market US$ Mn Forecast by Region, 2019 to 2034
Table 2: Global Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 3: Global Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 4: Global Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 5: Global Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 6: Global Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 7: Global Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 8: Global Market US$ Mn Forecast by End-User, 2019 to 2034
Table 9: North America Market US$ Mn Forecast by Country, 2019 to 2034
Table 10: North America Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 11: North America Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 12: North America Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 13: North America Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 14: North America Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 15: North America Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 16: North America Market US$ Mn Forecast by End-User, 2019 to 2034
Table 17: Latin America Market US$ Mn Forecast by Country, 2019 to 2034
Table 18: Latin America Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 19: Latin America Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 20: Latin America Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 21: Latin America Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 22: Latin America Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 23: Latin America Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 24: Latin America Market US$ Mn Forecast by End-User, 2019 to 2034
Table 25: Western Europe Market US$ Mn Forecast by Country, 2019 to 2034
Table 26: Western Europe Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 27: Western Europe Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 28: Western Europe Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 29: Western Europe Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 30: Western Europe Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 31: Western Europe Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 32: Western Europe Market US$ Mn Forecast by End-User, 2019 to 2034
Table 33: Eastern Europe Market US$ Mn Forecast by Country, 2019 to 2034
Table 34: Eastern Europe Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 35: Eastern Europe Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 36: Eastern Europe Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 37: Eastern Europe Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 38: Eastern Europe Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 39: Eastern Europe Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 40: Eastern Europe Market US$ Mn Forecast by End-User, 2019 to 2034
Table 41: East Asia Market US$ Mn Forecast by Country, 2019 to 2034
Table 42: East Asia Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 43: East Asia Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 44: East Asia Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 45: East Asia Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 46: East Asia Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 47: East Asia Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 48: East Asia Market US$ Mn Forecast by End-User, 2019 to 2034
Table 49: South Asia & Pacific Market US$ Mn Forecast by Country, 2019 to 2034
Table 50: South Asia & Pacific Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 51: South Asia & Pacific Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 52: South Asia & Pacific Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 53: South Asia & Pacific Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 54: South Asia & Pacific Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 55: South Asia & Pacific Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 56: South Asia & Pacific Market US$ Mn Forecast by End-User, 2019 to 2034
Table 57: MEA Market US$ Mn Forecast by Country, 2019 to 2034
Table 58: MEA Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 59: MEA Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 60: MEA Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 61: MEA Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 62: MEA Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 63: MEA Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 64: MEA Market US$ Mn Forecast by End-User, 2019 to 2034
List of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 6: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 7: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 8: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region, 2019 to 2034
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 11: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 12: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 13: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 14: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 15: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 16: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 17: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 18: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 19: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 20: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 21: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 22: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 23: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 24: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 25: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 26: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 27: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 28: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 29: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 30: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 31: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 32: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 33: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 34: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 35: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 36: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 37: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 38: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 39: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 40: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 41: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 42: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 43: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 44: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 45: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 46: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 47: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 48: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 49: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 50: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 51: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 52: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 53: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 54: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 55: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 56: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 57: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 58: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 59: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 60: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 61: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 62: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 63: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 64: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF